| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3122024 | Archives of Oral Biology | 2006 | 6 Pages |
SummaryObjectiveThe aim of this study was to analyse the antibacterial effects of Emdogain® Gel or its constituents on the growth of the suspected periodontopathogen Porphyromonas gingivalis.Study designThe effects of the proteins of enamel matrix derivative (EMD), the commercial product Emdogain® Gel or its vehicle propylene glycol alginate (PGA) (Straumann, Switzerland) on P. gingivalis growth were determined by two methods: broth dilution assay (BDA) and agar diffusion assay (ADA).ResultsBDA—Emdogain® Gel inhibited moderately the growth of P. gingivalis, whereas EMD showed no effect. The PGA vehicle inhibited the growth completely. ADA—Emdogain® Gel resulted in some inhibition in growth but was not significantly different from control. EMD revealed no zone of inhibition. PGA demonstrated statistically significant zones of inhibition.ConclusionEmdogain® Gel shows moderate antibacterial activities against P. gingivalis. These properties seem to be due to the PGA component of the gel preparation.
